Bitcoin
68196.32
-595.68
-0.87%
Crude Oil
63.73
+0.79
+1.24%
Gold
5013.1
+15.4
+0.31%
Copper
5.76
+0.01
+0.18%
Silver
76.56
+1.42
+1.85%
Dow Jones
49500.94
+48.95
+0.1%
SP500
6836.17
0
0%
NASDAQ
22546.67
-50.48
-0.22%

CheckMan Stock Market Overview

Trending Stocks

Name and Ticker
Last
% Change
% Change and Signal
Volume
Signal
80
+99.00%
Top Gainers
1,648,107
Top Gainers
3.45
+99.00%
Top Gainers
162,203
Top Gainers
6.75
+29.04%
Top Gainers
379,114
Top Gainers
8.29
+26.90%
Top Gainers
384,963
Top Gainers
213
+23.47%
Top Gainers
522,114
Top Gainers
1.03
+19.42%
Top Gainers
104,152
Top Gainers
2629
+19.02%
Top Gainers
263,936
Top Gainers
1.29
+18.60%
Top Gainers
818,935
Top Gainers
1685
+17.80%
Top Gainers
185,377
Top Gainers
3.15
+17.46%
Top Gainers
5,006,121
Top Gainers

Red List

Name and Ticker
Last
% Change
% Change and Signal
Volume
Signal
261
-368.20%
Top Loosers
926,457
Top Loosers
8.82
-160.09%
Top Loosers
215,283
Top Loosers
6
-106.33%
Top Loosers
810,291
Top Loosers
151
-37.75%
Top Loosers
156,659
Top Loosers
82700
-36.76%
Top Loosers
763,022
Top Loosers
113
-26.55%
Top Loosers
722,016
Top Loosers
2.04
-22.55%
Top Loosers
4,401,250
Top Loosers
1.98
-22.22%
Top Loosers
1,185,589
Top Loosers
42.14
-21.71%
Top Loosers
323,900
Top Loosers
2080
-18.44%
Top Loosers
536,381
Top Loosers

In Today's Headlines

Why Analysts Still See Big Upside in Salesforce After the SaaS Scare
03:33
16 Feb 2026
Why Analysts Still See Big Upside in Salesforce After the SaaS Scare

Salesforce NYSE: CRM stock price dropped significantly, presenting a deep-value opportunity amid the widespread sell-off of software stocks this year. The software-as-a-service (SaaS) apocalypse, however, is overblown, and analysts are taking note.

SEM to Report Q4 Earnings: Can Higher Admissions Protect Results?
03:30
16 Feb 2026
SEM to Report Q4 Earnings: Can Higher Admissions Protect Results?

Select Medical heads into Q4 earnings with EPS expected to be up 27.8% and revenues rising 3.7%, as key segments show growth.

ReNew Energy Global Plc (RNW) Q3 2026 Earnings Call Transcript
03:27
16 Feb 2026
ReNew Energy Global Plc (RNW) Q3 2026 Earnings Call Transcript

ReNew Energy Global Plc (RNW) Q3 2026 Earnings Call Transcript

XLE Surged 21.6% This Year as Oil Majors Navigate $64 Crude Reality
03:25
16 Feb 2026
XLE Surged 21.6% This Year as Oil Majors Navigate $64 Crude Reality

The Energy Select Sector SPDR Fund ( NYSEARCA:XLE ) has surged 21.6% year to date as markets pivot from energy transition rhetoric toward energy security concerns.

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages GSI Technology Inc. Investors to Inquire About Securities Class Action Investigation - GSIT
03:23
16 Feb 2026
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages GSI Technology Inc. Investors to Inquire About Securities Class Action Investigation - GSIT

New York, New York--(Newsfile Corp. - February 16, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GSI Technology Inc. (NASDAQ: GSIT) resulting from allegations that GSI Technology may have issued materially misleading business information to the investing public. SO WHAT: If you purchased GSI Technology securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Google (GOOGL) Cloud Revenue Just Surged 48% And May Have Delivered Knockout Blow To OpenAI
03:22
16 Feb 2026
Google (GOOGL) Cloud Revenue Just Surged 48% And May Have Delivered Knockout Blow To OpenAI

Summary: Our AI Investor Podcasts have been counting down the 12 trends that AI investors should be watching in 2026.

AGILON DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages agilon health, inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AGL
03:20
16 Feb 2026
AGILON DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages agilon health, inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AGL

New York, New York--(Newsfile Corp. - February 16, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of agilon health, inc. (NYSE: AGL) between February 26, 2025 and August 4, 2025, both dates inclusive (the "Class Period"), of the important March 2, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.

ROSEN, A LEADING LAW FIRM, Encourages Plug Power Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PLUG
03:18
16 Feb 2026
ROSEN, A LEADING LAW FIRM, Encourages Plug Power Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PLUG

New York, New York--(Newsfile Corp. - February 16, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Plug Power Inc. (NASDAQ: PLUG) between January 17, 2025 and November 13, 2025, inclusive (the "Class Period"), of the important April 3, 2026 lead plaintiff deadline. SO WHAT: If you purchased Plug Power securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Richtech Robotics Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - RR
03:17
16 Feb 2026
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Richtech Robotics Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - RR

New York, New York--(Newsfile Corp. - February 16, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Richtech Robotics Inc. (NASDAQ: RR) between January 27, 2026 and 12:00 PM ET on January 29, 2026, both dates inclusive (the "Class Period"), of the important April 3, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Richtech Robotics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to Expect From These Drug/Biotech Players This Earnings Season?
03:16
16 Feb 2026
What to Expect From These Drug/Biotech Players This Earnings Season?

Let's take a closer look at what awaits Bausch Health, Amicus Therapeutics, BioMarin Pharmaceutical, Insmed and Madrigal Pharmaceuticals as they prepare to report quarterly results this week.